|
Volumn 107, Issue 6, 2015, Pages
|
RE: Cost-effectiveness of prostate cancer screening: A simulation study based on ERSPC data
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
TUMOR MARKER;
BREAST CANCER;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER RISK;
CANCER SCREENING;
CANCER SURGERY;
CANCER SURVIVAL;
COMPUTER MODEL;
COST EFFECTIVENESS ANALYSIS;
EUROPEAN;
HEALTH CARE COST;
HUMAN;
LETTER;
MALE;
MATHEMATICAL MODEL;
NETHERLANDS;
PRIORITY JOURNAL;
PROSTATE CANCER;
RISK REDUCTION;
SIMULATION;
WATCHFUL WAITING;
BLOOD;
EARLY DIAGNOSIS;
ECONOMICS;
MASS SCREENING;
MORTALITY;
PROCEDURES;
PROSTATE TUMOR;
QUALITY ADJUSTED LIFE YEAR;
QUALITY OF LIFE;
EARLY DETECTION OF CANCER;
HUMANS;
MALE;
MASS SCREENING;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
QUALITY OF LIFE;
QUALITY-ADJUSTED LIFE YEARS;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 84930724774
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djv110 Document Type: Letter |
Times cited : (6)
|
References (7)
|